- Benchmark ASINB0F3JBFY6C
- MarketplaceUS
- Category ID8297530011
- Analyzed Products
- Keywordxeroform dressing, petrolatum dressing, non adherent gauze
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-26
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不适合新进入。 不是因为完全没人赚钱，而是因为利润正在被少数老牌和少数新牌锁死，最近新上架的失败占多数，已经进入高竞争、低容错的状态；对小商家尤其不友好，对大品牌也只是“有钱能试”，不是好赛道。
从数据看，市场只有2个新品牌，但新品牌新品成功率只有33.33%，失败率66.67%；更关键的是，全部新上架产品里，真正盈利的只有25.00%，而且近月新上架明显转差：2025年8月还有3个盈利、1个亏损，9月开始变成1个盈利、7个亏损，之后几乎只剩失败。利润上也不是健康区间里的均衡竞争：Greetmed 的成功款利润率在32.55%、28.11%、27.88%、27.88%，看似不错，但同品牌还有1个失败品；Gentell Select 7个新上架全部失败，0%成功。品牌层面，AWD Medical 这种老牌有2个老款稳定盈利，单品月销分别约300和200，利润率约30.22%和29.82%，但它2026年的新款直接失败，说明连老牌都在承压。市场里没有出现30~100+新品牌涌入的超饱和红线，但当前表现已经是明显的价格/投放压力市场，不是适合复制硬冲的环境。
- 大品牌可以看，但不是好机会。 你如果是外部大品牌，至少要准备接近老牌级别的产品改良和持续投放；可参考的只有 AWD Medical 的 B08LQYR376、B07K6BTV98 和 Greetmed 的 B0F66LBGVB、B0F3JBFY6C、B0F66LNS38、B0FSD78QBR，但要注意这些成功款多是“旧ASIN改良+低价+功能微差异”，不是纯创新空降。
- 小商家不建议进入。 真正能作为小商家案例的只有 Greetmed 这类新品牌少数成功款，且它的成功并不是低成本白手起家，而是已经做到单品牌约65.2万人民币月收入、300/325单位的体量，说明你现在的50万人民币预算虽然表面够做单个ASIN，但还不包含研发、品牌和认证，现实里不够支撑长期竞争。
- 警惕“假小商家”。 Gentell Select 的7个新款全部失败，且其中不少新品虽然评分看起来不差，但没有销量支撑，这更像是资源投入不足或竞争过热，不是普通小商家能靠常规打法翻盘的市场。
短结论：不建议推进。 如果一定要做，只能走大品牌式的产品升级和投放打法；小商家除非有明显功能升级、差异化设计和更强预算，否则不要进。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很明确：这个市场不适合现在进入。 新品牌里只有 Greetmed 这类少数样本跑通，但新品牌新品盈利率只有33.33%，非盈利率高达66.67%；更关键的是，老品牌新品盈利率是0%，而老品牌新品非盈利率是100%，这说明这里不是“谁都能赚”的市场，而是一个高度依赖已有资源和产品改良的筛选场。市场里没有出现30~100+新品牌蜂拥进入的证据，但老品牌新上架表现很差、价格竞争明显，整体更像高竞争、低容错的市场，不是值得小卖家冒险冲进去的地方。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?25.00%New listing success rate (old brands):0.00%New listing success rate (new brands):33.33%Which new brands have these successful new listings?Alternatives- 凡士林纱布/凡士林油纱：通常更便宜、渠道更广，适合需要减少粘连的常规伤口护理，但通常不带 Xeroform 的药理成分。
- 硅凝胶不粘敷料：很多情况下更容易买到、换药时更少粘连，使用体验更友好，尤其适合对舒适度要求高的轻中度伤口。
- 普通不粘伤口垫 + 无菌凡士林/药用软膏：可按需组合，成本往往更低，也更灵活，适合家庭临时处理和常备。
- 水凝胶敷料：对干燥或浅表创面更易上手，保湿性强，通常比专业抗菌油纱更容易在零售渠道找到。
- 透明薄膜敷料：适合浅表、低渗出伤口，贴用简单、观察方便，作为低成本、易操作的替代方案更具可得性。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场对新进入者仍然可做，但前提是复制“旧ASIN改良+低价”路线；如果按原样硬拼，结论是明显不适合盲目进入。 目前没有出现你定义的那种“新品牌大规模涌入”的过度饱和信号：已识别的新品牌样本里，Greetmed 4个盈利、1个亏损，盈利率80%；Gentell Select 7个里0个盈利，说明不是所有新品牌都能跑通，但也不是靠纯铺货就能赢。
Most investment in new productsNew products with Highest revenueLeast investment in new productsGreetmed
Recent Monthly Revenue (USD):$2,399.00(100pcs/month)B0F66LBGVB (4.7/5 (115 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableRecent Monthly Revenue (USD):$1,649.25(75pcs/month)B0F3JBFY6C (4.7/5 (115 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (USD):$1,349.25(75pcs/month)B0FSD78QBR (4.7/5 (115 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsAWD Medical
Recent Monthly Revenue (USD):$6,873.00(300pcs/month)B08LQYR376 (4.6/5 (3314 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
Recent Monthly Revenue (USD):$3,664.00(200pcs/month)B07K6BTV98 (4.6/5 (3314 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableLeast profitable new productsGentell Select
Recent Monthly Revenue (USD):-(-)B0FRP2CF4L (5/5 (2 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0FSLZ6JWY (5/5 (1 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0FT3XQGQT (4.7/5 (10 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 1英寸×8英寸长条小规格，和大号敷料差异明显
- |
- 单片独立包装，适合局部、小面积创面
- |
- 黄色油性不粘连外观，图片辨识度高，容易吸引点击
B0F66LBGVB (4.7/5 (115 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 5英寸×9英寸大规格，和小号产品区分明显
- |
- 25片独立装，更偏临床/家庭护理的大面积使用
- |
- 黄色敷料视觉醒目，产品图容易抓眼球
B0F3JBFY6C (4.7/5 (115 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing结论很明确：这个市场不值得进入。 不是因为完全没人赚钱，而是因为新品牌已经出现明显分化，容易赚钱的只集中在少数老牌和少数新牌里；对小商家来说，真正可复制的低风险机会几乎没有，进入后更像是在和价格战、品牌力、以及高投放硬拼。
Profitability difficultyPotential high net profit marginAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B08LQYR376AWD Medical2020-10-23Yes$22.91300pcs$6873.030.22%$2077.03B07K6BTV98AWD Medical2021-06-08Yes$18.32200pcs$3664.029.82%$1092.61B0F66LBGVBGreetmed2025-08-31Yes$23.99100pcs$2399.032.55%$780.88
B0CNTRTS9QOPTITEKNIK2023-11-22Yes$13.73200pcs$2746.022.9%$628.84
B0C3MRDQ8KOPTITEKNIK2023-04-26Yes$20.99100pcs$2099.028.14%$590.66
B0B3HZZ9S9EVERLIT2022-06-08Yes$20.89100pcs$2089.028.19%$588.89
B0DJQ9MWNPVive Care2024-10-09Yes$22.12100pcs$2212.026.62%$588.84B0F3JBFY6CGreetmed2025-08-31Yes$21.9975pcs$1649.2528.11%$463.61
B0C3MQBSVVOPTITEKNIK2023-04-26Yes$16.45100pcs$1645.024.53%$403.52B0FSD78QBRGreetmed2025-09-21Yes$17.9975pcs$1349.2527.88%$376.18
B0CNTQZ31HOPTITEKNIK2023-11-22Yes$13.99100pcs$1399.023.24%$325.13
B0F66LNS38Greetmed2025-08-31Yes$14.9975pcs$1124.2524.73%$278.03
B0DJQ8JQT1Vive Care2024-10-09Yes$20.050pcs$1000.027.0%$270.0
B0DJQ95DDTVive Care2024-10-09Yes$13.14100pcs$1314.019.03%$250.06
B0DJQ96SQXVive Care2024-10-09Yes$14.08100pcs$1408.016.59%$233.59
B0DX23RM1ZConkote2025-06-26Yes$19.9950pcs$999.518.86%$188.51
B0DX22SKH6Conkote2025-06-29Yes$14.9950pcs$749.518.92%$141.81Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0F66LBGVBGreetmed2025-08-31Yes$23.99100pcs$2399.032.55%$780.88B0F3JBFY6CGreetmed2025-08-31Yes$21.9975pcs$1649.2528.11%$463.61B0FSD78QBRGreetmed2025-09-21Yes$17.9975pcs$1349.2527.88%$376.18B0F66LNS38Greetmed2025-08-31Yes$14.9975pcs$1124.2524.73%$278.03#New Product Success Rates
Listing这个市场不值得进入：已明显偏向老品牌主导，且新品牌成功率只有25%，失败率75%，其中旧品牌的新产品是100%失败，说明竞争更像是“用老牌吃存量”，不是给新玩家留空间。 用户预算50万人民币看似够做单个ASIN，但在这个赛道里，钱不是主要问题，问题是进入后很容易被成熟品牌和低价标准款挤压，回本不稳定。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
GreetmedNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Gentell SelectOther#Success Rate by Entry Time
Listing这个市场不值得进入，已经接近价格战和拥挤状态。 近一年新品牌只有2个，表面上没到“30~100+新品牌涌入”的超饱和红线，但新品牌新品盈利率只有33.33%，新品牌新品失败率66.67%，而整体新上架产品盈利率只有25.00%，最近新增几乎都在亏或没跑通，说明竞争正在变硬，不是变容易。
证据很清楚：2025年新上架里，盈利的只有Greetmed的4个ASIN（B0F66LBGVB、B0F3JBFY6C、B0F66LNS38、B0FSD78QBR），对应利润率分别约32.55%、28.11%、27.88%、27.88%，但同品牌还有1个失败品B0FVDMSQHR；Gentell Select在2025年9月后连续7个新品全部失败，包括B0FRP2CF4L、B0FSLZ6JWY、B0FT3XQGQT、B0FRPGSR1H、B0FSMTJ3JW、B0FRPHJBHF、B0FXHG9CKN。按时间看，2025年8月还有3个成功、1个失败，到了9月直接变成1个成功、7个失败，之后10月到2026年基本只剩失败，说明市场在快速恶化。成功案例主要是老产品逻辑的改款，不是纯创新；而且像AWD Medical这种老品牌，旧款B08LQYR376和B07K6BTV98仍能维持29.82%~30.22%的利润，但它2026年的新品B0GMWTBTTP直接失败，说明连老牌都很难把新款打穿。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 3 1 0 11 2026 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 1 2025/8 0 0 0 0 2 1 0 1 2025/9 0 0 0 0 1 0 0 7 2025/10 0 0 0 0 0 0 0 1 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 1 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 1 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesOPTITEKNIKB0C3MQBSVV (4.7/5 (585 Reviews))Xeroform Petrolatum Dressing Non-Adherent Occlusive Fine Mesh Gauze Pad, Gentle Patch for Burns, Laceration, Surgical Incisions & Skin Grafts (4"x4" Pack of 25)
This listing is deemed profitablePrice (USD)$16.45Released TypeOld Release (2023-04-26)Brand is an old entry in this marketSize and Weight17.9 x 17.0 x 3.2 cm, 50.00gProfitable Factors
Based on old ASINLow pricing strategyDesign & Appearance
黄色无菌敷料主体，包装采用蓝白配色，辨识度较高, 4"x4"小尺寸方形细网纱片，25片装，偏向标准通用规格Key Buying Motive
凡士林浸渍的非粘连细网纱，适合低渗出伤口并减少换药时牵拉Target Customers
适合烧伤、裂伤、术后切口和皮肤移植等需要温和接触层的医护与家庭护理用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$1,645.00100 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight21.93% / 24.53%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight17.13% / 19.73%Peak / Non PeakSales & BSR Performance
OPTITEKNIKB0C3MRDQ8K (4.7/5 (587 Reviews))Xeroform Petrolatum Dressing Non-Adherent Occlusive Fine Mesh Gauze Pad, Gentle Patch for Burns, Laceration, Surgical Incisions & Skin Grafts (5"x9" Pack of 25)
This listing is deemed profitablePrice (USD)$20.99Released TypeOld Release (2023-04-26)Brand is an old entry in this marketSize and Weight20.7 x 12.6 x 5.3 cm, 50.00gProfitable Factors
Based on old ASINDistinct functions and featuresLow pricing strategyDesign & Appearance
黄色敷料本体在同类中较醒目，具备一定视觉识别度, 5"x9"大尺寸、25片装，偏临床/护理场景的规格组合更突出Key Buying Motive
凡士林浸润细密网状纱布，强调非粘连与半封闭保湿的基础护理功能Target Customers
面向需要烧伤、裂伤、手术切口和皮肤移植位点等低渗出伤口护理的家庭护理与临床用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$2,099.00100 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight25.67% / 28.14%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight20.33% / 22.79%Peak / Non PeakSales & BSR Performance
Loading samples... 29%